The percentage of non-standard quality (NSQ) drugs in tested samples has been steadily declining, pointing to improvements in quality assurance. Simultaneously, efforts to crack down on spurious medicines are intensifying, with a rise in raids on illicit drug manufacturing units, alongside arrests for the production, sale, or distribution of spurious or adulterated drugs.
Data reveals that the share of NSQ drugs in tested samples has nearly halved — dropping from around 5 per cent in 2014-15 to 2.8 per cent in 2021-22, according to an answer given in the Lok Sabha by Bharti Pravin Pawar, then minister of state for health and family welfare, in February last year.
Meanwhile, the number of spurious drugs flagged in random sample tests surged from 83 in 2014-15 to 379 in 2021-22. The overall number of samples tested also increased from 74,199 in 2014-15 to 88,844 in 2021-22. Alongside this, prosecutions and arrests have seen a sharp uptick, with cases of prosecution rising from 152 in 2014-15 to 592 in 2021-22, and arrests climbing from 85 to 450 during the same period, shows data in Lok Sabha answers.
This story is from the {{IssueName}} edition of {{MagazineName}}.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the {{IssueName}} edition of {{MagazineName}}.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
Engagement speaks louder than followers
Actions, not followers, are new social currency for Indians online, reveals Comscore Social's mid-year review
Post-monsoon showers to be above-normal this year: IMD
The India Meteorological Department (IMD) on Tuesday said that after a strong rainy season, the post-monsoon months will also be good. It predicts rainfall across the country in October to be 'above normal' at 115 per cent of the Long Period Average (LPA). The cumulative all-India rainfall for October is around 75.4 mm.
Substandard drugs on a decline amid crackdown
The first of a two-part series focuses on how quality audits and regulatory actions on pharma units nationwide are showing results
CHANGING CHANNELS
Carmakers are adding layers to their dealerships to reach more buyers and meet rising aspirations, while increasing revenue per car. Do they have the right products?
Time for caution on Nifty, but no need to panic
Historic trend does not flag immediate concern even as monthly RSI stood at 83 in Sep, indicating 'overbought' condition: Analysts
Indices fall for third day on FII outflows
Benchmark indices Sensex and Nifty edged lower on Tuesday, extending the losing run to the third day amid profit-taking in oil & gas and select FMCG stocks.
Larger gold loan players less impacted by RBI advisory
The Reserve Bank of India (RBI) has issued an advisory for entities giving gold loans (GL) where it identified irregular practices and gave three months for lenders to correct these and avoid supervisory action.
Brokerages revise fee as true-to-label norms kick in
Leading brokerages have revised their charges with the true-to-label norms by the Securities and Exchange Board of India (Sebi) kicking in from Tuesday.
Allegations against Buch: Sebi board lacks power to act, experts point out
The Securities and Exchange Board of India (Sebi) board meeting on Monday was expected to address allegations of disclosure lapses and conflicts of interest involving Chairperson Madhabi Puri Buch. However, two board members disclosed that the matter was not brought up, leaving some participants disappointed, especially in light of a slew of accusations from the country's main Opposition party, the Congress.
Industry divided on T+O impact
The Securities and Exchange Board of India (Sebi) has announced a slew of measures to infuse life into the same-day (T+0) settlement cycle. However, market players are divided over their effectiveness given the lack of interest in the framework in the present form.
